Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
16.6M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
10.4M
-
Shares change
-
+10.4M
-
Total reported value, excl. options
-
$85.3M
-
Value change
-
+$85.1M
-
Put/Call ratio
-
1.14
-
Number of buys
-
77
-
Price
-
$8.22
Significant Holders of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) as of Q2 2024
85 filings reported holding RIGL - RIGEL PHARMACEUTICALS INC - Common Stock as of Q2 2024.
RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.4M shares
of 16.6M outstanding shares and own 62.41% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.62M shares), BlackRock Inc. (1.51M shares), MORGAN STANLEY (1.42M shares), Soleus Capital Management, L.P. (1.04M shares), VANGUARD GROUP INC (962K shares), ACADIAN ASSET MANAGEMENT LLC (550K shares), GEODE CAPITAL MANAGEMENT, LLC (391K shares), STATE STREET CORP (365K shares), Stonepine Capital Management, LLC (305K shares), and JACOBS LEVY EQUITY MANAGEMENT, INC (238K shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.